Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Apogee Therapeutics, Inc. has filed 290 SEC EDGAR filings since 28 Apr 2023

SEC filing history

Showing 251-275 of 290 matching filings.

Per page
25
Current page
11
SC 13D File 005-94122

SC 13D

Filing date
28 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
25 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94122

SC 13G filing

Filing date
24 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-94122

SC 13D

Filing date
21 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

OWNERSHIP DOCUMENT

Filing date
17 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

OWNERSHIP DOCUMENT

Filing date
17 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

OWNERSHIP DOCUMENT

Filing date
17 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

OWNERSHIP DOCUMENT

Filing date
17 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

OWNERSHIP DOCUMENT

Filing date
17 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-272831

424B4

Filing date
17 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-272831

EFFECT filing

Filing date
13 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-273236

S-1MEF

Filing date
13 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-41740

CERT filing

Filing date
12 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .